Fresenius CEO on why Quirónsalud acquisition was good business

Fresenius Helios has presented its acquisition of Quirónsalud to investors. CEO Stephan Sturm detailed the synergies it expects from the deal, which he says will lead to EBITDA margins of 20% by 2017 for Quirón.

We would welcome your thoughts on this story. Email your views to Claude Risner or call 0207 183 3779.

Article Tags

HBI Market Overviews

Hospital (For-Profit)

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.